Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.530
-0.017 (-3.11%)
At close: Jun 26, 2026, 4:00 PM EDT
0.580
+0.050 (9.43%)
After-hours: Jun 26, 2026, 7:29 PM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,571
Profits / Employee
-$1,361,417
Market Cap
13.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 24 |
| Curis | 24 |
| BioCardia | 21 |
| IN8bio | 18 |
| SeaStar Medical Holding | 17 |
| CalciMedica | 16 |
| Tvardi Therapeutics | 12 |
| Cocrystal Pharma | 10 |
LEXX News
- 2 days ago - Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing - TheFly
- 2 days ago - Lexaria's Human Study GLP-1-H26-7 has Begun Dosing on Schedule - TheNewswire
- 2 days ago - Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule - Accesswire
- 4 days ago - Lexaria Bioscience begins dosing in animal study GLP-1-A26-1 - TheFly
- 4 days ago - Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule - Accesswire
- 4 days ago - Lexaria's Animal Study GLP-1-A26-1 has Begun Dosing on Schedule - TheNewswire
- 10 days ago - Lexaria Bioscience provides update on GLP-1 oral pill market - TheFly
- 10 days ago - GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand - Accesswire